facebook
twitter
rss
account
search
search
 

Drug combo increases brain tumor survival

March 9, 2009 at 2:53 PM   |   Comments

BONN, Germany, March 9 (UPI) -- German and Swiss scientists say they have used the combination of two drugs to achieve a substantial improvement in the treatment of certain brain tumors.

The researchers led by Professor Dr. Ulrich Herrlinger of the University of Bonn treated 39 patients who had been diagnosed with a gliablastoma. The patients -- treated with a combination of temozolomide and lomustine -- survived on average 23.1 months, while with the standard therapy the mean would have been 14.6 months, the researchers said.

"This unusually manifest extension of the survival time has surprised even us," said Herrlinger. "Our results offer the opportunity to improve our grip on this aggressive form of cancer. Now, further investigations involving a larger number of patients are needed to optimize this therapy."

The study is reported in the February issue of the Journal of Clinical Oncology.

© 2009 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Most Popular
1
Mount St. Helens shows signs of awakening Mount St. Helens shows signs of awakening
2
Windows 9 expected to be previewed Tuesday after leaks get the jump on Microsoft Windows 9 expected to be previewed Tuesday after leaks get the jump on Microsoft
3
Social network Ello getting thousands of requests per hour Social network Ello getting thousands of requests per hour
4
India's Mars Orbiter spots dust storm in Martian surface photo India's Mars Orbiter spots dust storm in Martian surface photo
5
Study: dolphins attracted to magnets Study: dolphins attracted to magnets
Trending News
x
Feedback